Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0CX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,659
Award facts
- Contract value 100% obligated
- $36,658.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,658.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens (2 ml units) on December 12, 2025, with an ultimate completion date of December 15, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor vehicle designed to supply pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps. This delivery order supports the Defense Health Agency's pharmaceutical supply chain for military beneficiaries and other federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor, maintains a significant portfolio of federal medical supply contracts and demonstrates capability to fulfill complex, competitive federal procurement requirements across multiple therapeutic domains for defense and military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FR0CX?
SPE2DR26FR0CX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FR0CX worth?
The government has obligated $36,659 on SPE2DR26FR0CX.
Is contract SPE2DR26FR0CX an order under another contract?
Yes. SPE2DR26FR0CX is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0CX competed?
The extent of competition for SPE2DR26FR0CX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award